US5639672A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Electrochemical determination of fructosamine
Assignee: Diabetes Diagnostics Inc
•
Filing: 1995-10-16
•
Granted: 1997-06-17
•
Expires: 2015-10-16
Abstract
Abstract The present invention relates to a method for electrochemically measuring the concentration of fructosamine, or its high alkalinity eneaminol tautomer in a body fluid sample.
Inventors
- 👤 John F. Burd
- 👤 Gebhard Neyer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-30 02:51
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/551; G01N33/553; C; C12; C12Q; C12Q1/00; C12Q1/001; C12Q1/005; Y; Y10; Y10S; Y10S436/00; Y10S436/806; Y10S436/815; Y10T; Y10T436/00; Y10T436/17; Y10T436/173845; Y10T436/25
Claims Analysis
Total Claims: 31
Claim 1
Independent Claim
136 words
A method for electrochemically determining the concentration of a fructosamine in a body fluid sample of a patient comprising the steps of: a. contacting said body fluid sample with a buffering agent and a biosensor, said biosensor comprising an anode and a cathode; b. applying a voltage to the anode; c. measuring the electrical current passing between the anode and cathode; and d. comparing the amount of current measured to a standard curve of current versus concentration of fructosamine, as determined for said body fluid in order to determine the concentration of the fructosamine in said body fluid; wherein said buffering agent adjusts the pH of body fluid sample to between about 10 to about 12.5, and said buffering agent may be on the biosensor or otherwise added to the sample before the current is measured.
Claim 2
Independent Claim
136 words
A method for electrochemically determining the concentration of a fructosamine in a body fluid sample of a patient comprising the steps of: a. contacting said body fluid sample with a buffering agent and a biosensor, said biosensor comprising an anode and a cathode; b. applying a voltage to the anode; c. measuring the electrical current passing between the anode and cathode; and d. comparing the amount of current measured to a standard curve of current versus concentration of fructosamine, as determined for said body fluid in order to determine the concentration of the fructosamine in said body fluid; wherein said buffering agent adjusts the pH of body fluid sample to between about 10 to about 12.5, and said buffering agent may be on the biosensor or otherwise added to the sample before the current is measured.
Claim 3
Dependent Claim
17 words
A method of claim 1, wherein the anode comprises a transition metal or a form of carbon.
Claim 4
Dependent Claim
14 words
A method of claim 2, wherein the anode is glassy carbon, platinum, or gold.
Claim 5
Dependent Claim
22 words
A method of claim 1, wherein the pH of the anolyte is adjusted to a pH of about 10.5 to about 11.5.
Claim 6
Dependent Claim
28 words
A method of claim 1, further comprising contacting a reference electrode simultaneously with the body fluid sample and measuring the voltage between the reference electrode and the anode.
Claim 7
Dependent Claim
14 words
A method of claim 5, wherein the reference electrode is a silver/silver chloride electrode.
Claim 8
Dependent Claim
115 words
A method of claim 1, additionally comprising: a. contacting the body fluid sample with a second biosensor, said second biosensor utilizing the same buffering agent, anode and cathode as said biosensor; b. contacting said body fluid sample with a fructosamine binding agent; c. applying the identical voltage to the second anode; d. additionally measuring the current between the anode and cathode of the second biosensor; e. subtracting the current measured by the second biosensor from that measured for the other biosensor; and f. comparing the difference of the two values to said standard curve; wherein said fructosamine binding agent may be on the biosensor or otherwise added to said sample before the current is measured.
Claim 9
Dependent Claim
25 words
A method of claim 7, wherein the fructosamine binding agent is boric acid, one or more boronic acid derivatives, or one or more anti-(fructosamine) antibodies.
Claim 10
Independent Claim
136 words
A method for electrochemically determining the concentration of a fructosamine in a body fluid sample of a patient, comprising the steps of: a. contacting the body fluid sample with one or more mediators, a buffering agent and a biosensor comprised of an anode and cathode; b. applying a voltage to the anode; c. measuring the electrical current passing between the anode and cathode; and d. comparing the amount of current measured to a standard curve of current versus concentration of fructosamine in the presence of said one or more mediators, as determined for said body fluid; wherein said buffering agent and mediator are on the biosensor or otherwise added to the sample before said current is measured; and said buffering agent adjusts the pH of said body fluid sample to between about 4 to about 12.5.
Claim 11
Independent Claim
136 words
A method for electrochemically determining the concentration of a fructosamine in a body fluid sample of a patient, comprising the steps of: a. contacting the body fluid sample with one or more mediators, a buffering agent and a biosensor comprised of an anode and cathode; b. applying a voltage to the anode; c. measuring the electrical current passing between the anode and cathode; and d. comparing the amount of current measured to a standard curve of current versus concentration of fructosamine in the presence of said one or more mediators, as determined for said body fluid; wherein said buffering agent and mediator are on the biosensor or otherwise added to the sample before said current is measured; and said buffering agent adjusts the pH of said body fluid sample to between about 4 to about 12.5.
Claim 12
Dependent Claim
30 words
A method of claim 9, wherein the mediator is chosen from the group consisting of ferrocene, a nitro blue tetrazolium salt, a tris ruthenium complex, or a tris osmium complex.
Claim 13
Dependent Claim
17 words
A method of claim 10, wherein the anode comprises a transition metal or a form of carbon.
Claim 14
Dependent Claim
14 words
A method of claim 11, wherein the anode is glassy carbon, platinum, or gold.
Claim 15
Dependent Claim
24 words
A method of claim 9, wherein the pH of the body fluid sample is adjusted to a pH of about 10.5 to about 11.5.
Claim 16
Dependent Claim
27 words
A method of claim 9, additionally comprising contacting the body fluid sample with a reference electrode and measuring the voltage between the reference electrode and the anode.
Claim 17
Dependent Claim
14 words
A method of claim 14, wherein the reference electrode is a silver/silver chloride electrode.
Claim 18
Dependent Claim
20 words
A method of claim 10, wherein the mediator is a nitro blue tetrazolium salt and the pH is about 10.3.
Claim 19
Dependent Claim
10 words
A method of claim 10, wherein the mediator is ferrocene.
Claim 20
Dependent Claim
115 words
A method of claim 9, additionally comprising: a. contacting the body fluid sample with a second biosensor, said second biosensor utilizing the same buffering agent, anode and cathode as said biosensor; b. contacting said body fluid sample with a fructosamine binding agent; c. applying the identical voltage to the second anode; d. additionally measuring the current between the anode and cathode of the second biosensor; e. subtracting the current measured by the second biosensor from that measured for the other biosensor; and f. comparing the difference of the two values to said standard curve; wherein said fructosamine binding agent may be on the biosensor or otherwise added to said sample before the current is measured.
Claim 21
Dependent Claim
25 words
A method of claim 18, wherein the fructosamine binding agent is boric acid, one or more boronic acid derivatives, or one or more anti-(fructosamine) antibodies.
Claim 22
Independent Claim
133 words
A method for electrochemically determining the concentration of a fructosamine in a body fluid sample of a patient, comprising the steps of: a. contacting the body fluid sample with an oxidoreductase enzyme, a buffering agent and a biosensor comprised of an anode and cathode; b. applying a voltage to the anode; c. measuring the electrical current passing between the anode and cathode; and d. comparing the amount of current measured to a standard curve of current versus concentration of fructosamine in the presence of said oxidoreductase enzyme, as determined for said body fluid; wherein said buffering agent and enzyme are on the biosensor or otherwise added to the sample before said current is measured; and said buffering agent adjusts the pH of said body fluid sample to between about 4 to about 10.
Claim 23
Independent Claim
133 words
A method for electrochemically determining the concentration of a fructosamine in a body fluid sample of a patient, comprising the steps of: a. contacting the body fluid sample with an oxidoreductase enzyme, a buffering agent and a biosensor comprised of an anode and cathode; b. applying a voltage to the anode; c. measuring the electrical current passing between the anode and cathode; and d. comparing the amount of current measured to a standard curve of current versus concentration of fructosamine in the presence of said oxidoreductase enzyme, as determined for said body fluid; wherein said buffering agent and enzyme are on the biosensor or otherwise added to the sample before said current is measured; and said buffering agent adjusts the pH of said body fluid sample to between about 4 to about 10.
Claim 24
Dependent Claim
39 words
A method of claim 20, additionally comprising contacting said body fluid sample with one or more mediators or factors, wherein said mediators is initially on the biosensor or otherwise is added to said sample before said current is measured.
Claim 25
Dependent Claim
19 words
A method of claim 20 or 21, wherein said enzyme is fructosyl N-alkyl amino acid oxidase or fructosylamine oxidase.
Claim 26
Dependent Claim
26 words
A method of claim 21, wherein said one or mediators or cofactors is ferrocene, nitro blue tetrazolium, a tris ruthenium complex, or a tris osmium complex.
Claim 27
Dependent Claim
18 words
A method of claim 21, wherein said mediators or cofactors are nicotinamide adenine dinucleotide or flavin adenine dinucleotide.
Claim 28
Dependent Claim
17 words
A method of claim 20, wherein the anode comprises a transition metal or a form of carbon.
Claim 29
Dependent Claim
14 words
A method of claim 25, wherein the anode is glassy carbon, platinum or gold.
Claim 30
Dependent Claim
28 words
A method of claim 20, further comprising simultaneously contacting said body fluid sample with a reference electrode and measuring the voltage between the reference electrode and the anode.
Claim 31
Dependent Claim
14 words
A method of claim 27, wherein said reference electrode is a silver/silver chloride electrode.
References Cited (Backward Citations)
US4545382A
Cited
US4642295A
Cited
US4645742A
Cited
US4478744A
Cited
US4511659A
Cited
US4711245A
Cited
US4883057A
Cited
US4820636A
Cited
US4837166A
Cited
US5206144A
Cited
JPS61268178A
Cited
US4876205A
Cited
US4806468A
Cited
EP0593096A2
Cited
US5124253A
Cited
US5264106A
Cited
US4956301A
Cited
JPH03155780A
Cited
US5183739A
Cited
EP0473189A2
Cited
EP0526150A1
Cited
US5387109A
Cited
EP0573942A1
Cited
US5385846A
Cited
US5470752A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-06-16 | 2000-12-16 | 2001-06-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-06-16 | 2004-12-16 | 2005-06-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-06-16 | 2008-12-16 | 2009-06-17 | $7700.00 | Window Closed / Lapsed |